stockrowAlvotech (ALVO) vs Phibro Animal Health Corporation (PAHC)
- Alvotech ALVO 4.86 +6.81%
- Phibro Animal Health Corporation PAHC 33.75 −4.66%
Alvotech and Phibro Animal Health Corporation are both Drug Manufacturers Specialty & Generic companies. Alvotech is the larger, with a market value of $1.8B against $1.4B — 1.2× the size. Alvotech has negative trailing earnings, so its P/E is not meaningful; Phibro Animal Health Corporation trades at 14.0×. Alvotech grew revenue faster over the last twelve months: 364.3% against 10.1%. Phibro Animal Health Corporation has the higher net margin (6.67% vs −101.1%) and the higher return on invested capital (11.3% vs 0.00%). Across the 17 metrics below, Phibro Animal Health Corporation leads on 13 and Alvotech on 4.
Valuation
Profitability
| Metric | ALVO | PAHC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 42.71% | 33.83% | 53.51% |
| Operating margin | (42.43%) | 12.51% | 0.00% |
| Net margin | (101.05%) | 6.67% | (2.45%) |
| Free cash flow margin | 0.00% | 1.41% | 0.00% |
| Return on equity | 0.00% | 28.17% | (0.80%) |
| Return on assets | 0.00% | 7.08% | (1.67%) |
| Return on invested capital | 0.00% | 11.27% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack